Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
      Description

      The purpose of this study is to determine if ganetespib (STA-9090) is effective in the treatment of patients with HER2+ or triple negative breast cancer who have not received prior systemic treatment in the metastatic setting.

      Conditions
      Breast CancerHER-2 Positive Breast CancerTriple Negative Breast CancerER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment
      Talk to us